Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| pathophysiology of prostate cancer |
|
The pathophysiology of lower urinary tract symptoms after pathophysiology underlying the lower urinary. tract symptoms (LUTS) persisting for. ≥6 months after brachytherapy for localized. prostate cancer. Pathophysiology of bone metastases from prostate cancer and the Metastasis to bone is a common feature in advanced prostate cancer patients. Current treatments, while effective in suppressing tumour growth and relieving IngentaConnect Skeletal complications of prostate cancer Skeletal complications of prostate cancer: Pathophysiology and therapeutic potential of bisphosphonates. Author: Green, Jonathan1 Oncology Nursing Society Topics included the pathophysiology of bone metastases, management of skeletal complications, and changes and challenges of advanced prostate cancer. Epidemiology and pathophysiology of prostate cancer in African Epidemiology and pathophysiology of prostate cancer in African-American men. Powell IJ. Department of Urology, Karmanos Cancer Institute, Novartisoncology.com - Prostate Cancer Disease Introduction / Part II The way in which prostate cancer grows, or the path it takes if it leaves the original tumor, is its pathophysiology. If it does spread, the cancer tends to The Journal of Urology : Epidemiology and Pathophysiology of Epidemiology and Pathophysiology of Prostate Cancer in African-American Men. Isaac J. Powell Corresponding Author Contact Information Prostate Cancer The pathophysiology of prostate cancer is poorly understood and for many years was an underrepresented area of investigation, in contrast to work in colon Prostate cancer - Wikipedia, the free encyclopedia Prostate cancer is a disease in which cancer develops in the prostate, 1 Prostate; 2 Symptoms; 3 Pathophysiology; 4 Etiology; 5 Prevention eMedicine - Prostate Cancer: Biology, Diagnosis, Pathology Pathophysiology. Prostate cancer develops when the rates of cell division and cell death are no longer equal, leading to uncontrolled tumor growth. |
| pathophysiology of prostate cancer |
|
prostate brachytherapy multidisciplinary prostate cancer symposium prostate blood urine prostate cancer and smoking |